Cardiovascular Risk Factors and Haematological Indexes of Inflammation in Paralympic Athletes with Different Motor Impairments
Table 1
Framingham Score and MetS criteria (NCEP-ATP III).
PA-SCI-H ()
PA-SCI-L ()
PA-LLA ()
PA-ULI ()
Framingham score
Age (years) (sex (all men))
Smokers
2/13
1/12
4/15
1/10
CHOL (mg/dL)
178 (139-201)
207 (162-229)
209 (188-235)
200 (192-210)
HDL (mg/dL) (NCEP-ATP III: <40)
vs. SCI-H
vs. SCI-H
SBP (mmHg) (NCEP-ATP III: ≥130)
120 (110-122)
122 (120-130)
120 (110-130)
120 (117-121)
Met-S criteria (NCEP-ATP III) not included in the Framingham Score
DBP (mmHg) (NCEP-ATP III: ≥ 85)
75 (70-80)
80 (72-85)
80 (60-85)
72 (67-80)
W (cm) (NCEP-ATP III: >102)
82 (76-98)
80 (77-90)
89 (80-97)
82 (73-87)
GLU (mg/dL) (NCEP-ATP III: ≥100)
vs. LLA
vs. LLA
vs. LLA >
TG (mg/dL) (NCEP-ATP III: ≥150)
87 (79-115)
59 (43-103)
97 (65-160)
64 (56-93)
Met-S (NCEP-ATP III)
0.5 (0.0-1.0) vs. LLA
0.5 (0.0-1.8) vs. LLA
2.0 (1.0-3.0)
1.0 (0.0-1.0)
LDL (mg/dL)
LDL/HDL
2.4 (1.5-3.2)
1.8 (1.2-2.6)
2.2 (1.8-3.8)
2.1 (1.7-2.2)
CHOL/HDL
3.7 (2.8-4.6)
3.0 (2.4-3.9)
3.4 (3.0-5.7)
3.3 (2.9-3.4)
MetS: metabolic syndrome; NCEP-ATP III: National Cholesterol Education Program—Third Adult Treatment Panel; CHOL: cholesterol; HDL: high-density lipoproteins; SBP: systolic blood pressure; DBP: diastolic blood pressure; W: waist circumference; GLU: glucose; TG: triglycerides. Data are expressed as mean and SEM (normality test (Shapiro-Wilk) passed; One Way Analysis of Variance, followed by All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method)) or median and interquartile range (25%-75%) (normality test (Shapiro-Wilk) failed; Kruskal-Wallis One Way Analysis of Variance on Ranks, followed by All Pairwise Multiple Comparison Procedures (Dunn’s Method)).
